These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 10193574
1. Antioxidant BO-653 and human macrophage-mediated LDL oxidation. Müller K, Carpenter KL, Freeman MA, Mitchinson MJ. Free Radic Res; 1999 Jan; 30(1):59-71. PubMed ID: 10193574 [Abstract] [Full Text] [Related]
2. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages. Hunt JV, Bottoms MA, Taylor SE, Lyell V, Mitchinson MJ. Free Radic Res; 1994 Mar; 20(3):189-201. PubMed ID: 8019642 [Abstract] [Full Text] [Related]
3. Oxidation of low-density lipoprotein by human monocyte-macrophages results in toxicity to the oxidising culture. Marchant CE, Van der Veen C, Law NS, Hardwick SJ, Carpenter KL, Mitchinson MJ. Free Radic Res; 1996 May; 24(5):333-42. PubMed ID: 8733937 [Abstract] [Full Text] [Related]
4. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. Jialal I, Grundy SM. J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843 [Abstract] [Full Text] [Related]
5. Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion. Müller K, Carpenter KL, Mitchinson MJ. Free Radic Res; 1998 Sep; 29(3):207-20. PubMed ID: 9802552 [Abstract] [Full Text] [Related]
6. Oxidized low-density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants. Marchant CE, Law NS, van der Veen C, Hardwick SJ, Carpenter KL, Mitchinson MJ. FEBS Lett; 1995 Jan 23; 358(2):175-8. PubMed ID: 7828731 [Abstract] [Full Text] [Related]
7. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design. Noguchi N, Okimoto Y, Tsuchiya J, Cynshi O, Kodama T, Niki E. Arch Biochem Biophys; 1997 Nov 01; 347(1):141-7. PubMed ID: 9344475 [Abstract] [Full Text] [Related]
8. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells. Walters-Laporte E, Furman C, Fouquet S, Martin-Nizard F, Lestavel S, Gozzo A, Lesieur D, Fruchart JC, Duriez P, Teissier E. J Cardiovasc Pharmacol; 1998 Oct 01; 32(4):582-92. PubMed ID: 9781926 [Abstract] [Full Text] [Related]
9. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Lee HS, Jeong JY, Kim BC, Kim YS, Zhang YZ, Chung HK. Kidney Int; 1997 Apr 01; 51(4):1151-9. PubMed ID: 9083281 [Abstract] [Full Text] [Related]
10. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Negre-Salvayre A, Alomar Y, Troly M, Salvayre R. Biochim Biophys Acta; 1991 Jun 05; 1096(4):291-300. PubMed ID: 2065102 [Abstract] [Full Text] [Related]
11. The oxidative modification of low-density lipoproteins by macrophages. Leake DS, Rankin SM. Biochem J; 1990 Sep 15; 270(3):741-8. PubMed ID: 2122885 [Abstract] [Full Text] [Related]
12. Inhibition of human low-density lipoprotein oxidation in vitro by Maharishi Ayur-Veda herbal mixtures. Sharma HM, Hanna AN, Kauffman EM, Newman HA. Pharmacol Biochem Behav; 1992 Dec 15; 43(4):1175-82. PubMed ID: 1475302 [Abstract] [Full Text] [Related]
13. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Iuliano L, Colavita AR, Camastra C, Bello V, Quintarelli C, Alessandroni M, Piovella F, Violi F. Br J Pharmacol; 1996 Dec 15; 119(7):1438-46. PubMed ID: 8968553 [Abstract] [Full Text] [Related]
14. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein. Rojstaczer N, Triggle DJ. Biochem Pharmacol; 1996 Jan 26; 51(2):141-50. PubMed ID: 8615882 [Abstract] [Full Text] [Related]
15. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation. Hanna AN, Titterington LC, Lantry LE, Stephens RE, Newman HA. Biochem Pharmacol; 1995 Nov 09; 50(10):1627-33. PubMed ID: 7503765 [Abstract] [Full Text] [Related]
16. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Thomas SR, Neuzil J, Stocker R. Arterioscler Thromb Vasc Biol; 1996 May 09; 16(5):687-96. PubMed ID: 8963727 [Abstract] [Full Text] [Related]
17. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Guyton JR, Lenz ML, Mathews B, Hughes H, Karsan D, Selinger E, Smith CV. Atherosclerosis; 1995 Dec 09; 118(2):237-49. PubMed ID: 8770318 [Abstract] [Full Text] [Related]
18. Inhibitory effects of multi-substituted benzylidenethiazolidine-2,4-diones on LDL oxidation. Jeong TS, Kim JR, Kim KS, Cho KH, Bae KH, Lee WS. Bioorg Med Chem; 2004 Aug 01; 12(15):4017-23. PubMed ID: 15246079 [Abstract] [Full Text] [Related]
19. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue. Iuliano L, Pedersen JZ, Camastra C, Bello V, Ceccarelli S, Violi F. Free Radic Biol Med; 1999 Apr 01; 26(7-8):858-68. PubMed ID: 10232829 [Abstract] [Full Text] [Related]
20. Inhibition of low density lipoprotein oxidation by thyronines and probucol. Hanna AN, Feller DR, Witiak DT, Newman HA. Biochem Pharmacol; 1993 Feb 09; 45(3):753-62. PubMed ID: 8442772 [Abstract] [Full Text] [Related] Page: [Next] [New Search]